ResearcherUNSW SydneyNo recent work listed

Hyerim Suh

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0003-3728-9058; OpenAlex author ID A5078544162.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 2

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

Bromelain and acetylcysteine (BromAc®) alone and in combination with gemcitabine inhibit subcutaneous deposits of pancreatic cancer after intraperitoneal injec… Co-author PMID 35035694 ↗
Mucins in pancreatic cancer: biological role, implications in carcinogenesis and applications in diagnosis and therapy. First author PMID 28670497 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

David Lawson Morris · 2 shared papers, 2017–2021
- Paper Bromelain and acetylcysteine (BromAc®) alone and in combination with gemcitabine inhibit subcutaneous deposits of pancr… PMID 35035694 ↗
- Paper Mucins in pancreatic cancer: biological role, implications in carcinogenesis and applications in diagnosis and therapy. PMID 28670497 ↗
Ahmed H. Mekkawy · 1 shared paper, 2021
- Paper Bromelain and acetylcysteine (BromAc®) alone and in combination with gemcitabine inhibit subcutaneous deposits of pancr… PMID 35035694 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.